Phase 1 Environmental Risk Assessment (ERA)
/in Pharmaceutical Safety and Efficacy (PSE)/by Roy JacobsQuantitative Structure-Activity Relationship (QSAR) assessment according ICH-M7
/in Pharmaceutical Safety and Efficacy (PSE)/by Roy JacobsHealth based exposure limits (HBEL)
/in Pharmaceutical Safety and Efficacy (PSE), Regulatory affairs/by Roy JacobsClinical and non-clinical sections of the registration dossier
/in Pharmaceutical Safety and Efficacy (PSE)/by Dave JacobsAdvise on study designs (PK, PD, clinical and PASS)
/in Pharmaceutical Safety and Efficacy (PSE)/by Dave JacobsDADA CONSULTANCY
CATEGORIES
BUSINESS HOURS
Our customer support is available from 9am to 5pm: +31 24 373 03 09
Monday-Friday: 9am to 5pm
Saturday: Closed
Sunday: Closed